American Shared Hospital Services (AMS:NYSEMKT) closed at $1.27 on October 14, 2026, unchanged on the day. The stock trades 46.9% below its 52-week high of $2.39 and 5.0% above its 52-week low of $1.21. Over the past year, it lost 44.8%. American Shared Hospital Services is part of the Health Care sector (Medical Specialities).
| 5D | 1M | 3M | 6M | 1Y |
|---|---|---|---|---|
| 0.00% | -10.56% | -11.19% | -9.93% | -44.78% |
In 252 trading sessions since October 14, 2025, AMS closed higher on 93 days (37%). Its best day was May 1, 2026 (+17.24%) and its worst was March 31, 2026 (-19.89%). The stock moved 10% or more in a single session 10 times. It opened at least 5% above the previous day's high 4 times.
American Shared Hospital Services, together with its subsidiaries, leases radiosurgery and radiation therapy equipment to health care providers in the United States and internationally. It offers radiosurgery equipment for the Gamma Knife stereotactic radiosurgery, a non-invasive procedure for the treatment of malignant and benign brain tumors, and arteriovenous malformations, as well as functional disorders, such as trigeminal neuralgia. The company also provides image guided radiation therapy systems and related equipment that integrate imaging and detection components into an accelerator, which enables clinicians to plan treatment, verify positioning, and deliver treatment. In addition, it offers financing services for Elekta Gamma Knife units. Further, the company provides proton beam therapy services in Long Beach, California and Orlando, Florida, as well as planning, installation, reimbursement, and marketing support services to its customers. Additionally, it is developing a medical device for the treatment of cancer patients using proton beam radiation therapy. As of March 1, 2016, the company operated 17 Gamma Knife units, as well as served 17 medical centers in 16 states...
Find more stocks like AMS with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.